Polestar Automotive (PSNY) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
28 Jul, 2026Executive summary
Q4 2024 retail sales reached 12,256 units, a 5.3% increase compared to Q4 2023, driven by an expanded model line-up.
Full-year 2024 retail sales totaled 44,851 units, representing a 15% decrease year-over-year.
Order intake in Q4 2024 surged 37.2% versus Q4 2023, with Polestar 3 and 4 accounting for 56% of orders.
Financial highlights
Q4 2024 retail sales: 12,256 units, up 5.3% year-over-year.
Full-year 2024 retail sales: 44,851 units, down 15% from 2023.
Q4 2024 order intake increased 37.2% year-over-year; full-year order intake up 37.9%.
Outlook and guidance
Strong order momentum entering 2025, supported by recent commercial operation changes.
Management to provide further business and strategy updates in January 2025.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Polestar Automotive
- 2024 guidance updated: lower sales, improved cost control, and positive EBITDA targeted for 2025.PSNY
Investor Update8 Jul 2026 - Record sales, four new models, and a 25% emissions cut drive growth and sustainability.PSNY
Status update8 Jul 2026 - Q1 sales rose 7%, but gross margin turned negative and net loss widened amid pricing and tariff pressures.PSNY
Q1 20267 May 2026 - Record sales and revenue growth, improved margins, and strong equity raise support 2026 outlook.PSNY
Q4 202522 Apr 2026 - Q2 deliveries up 80%, but Q1 revenue and margins declined sharply amid ongoing cost cuts.PSNY
Q1 20243 Feb 2026 - Q2 deliveries surged 80%+ sequentially, but revenue and margins fell year-over-year.PSNY
Q2 202423 Jan 2026 - Q1 2025 delivered 84% revenue growth and a positive margin, led by new model launches.PSNY
Q1 202517 Nov 2025 - 49% revenue growth and strong retail expansion offset by higher net loss and margin pressure.PSNY
Q3 202512 Nov 2025 - Retail sales up 51.1% and revenue up 56.5% in H1 2025, with improved margins despite $739M impairment.PSNY
Q2 202510 Sep 2025